The European medicines regulator on Thursday approved Covid-19 vaccines adapted to the Omicron variant from Pfizer/BioNTech and Moderna.

The vaccines "target the Omicron BA.1 subvariant in addition to the original strain" of the coronavirus, the Amsterdam-based European Medicines Agency (EMA) said in a statement.

More information to follow on 20minutes.fr…/…

  • Health

  • Covid-19

  • Covid vaccine

  • Coronavirus

  • Variant Omicron

  • Vaccination